Financial disclosures.
Full transparency about the financial relationships behind the clinical content on this site.
Why this page exists
We disclose every financial relationship that touches the clinical content.
The treatment Dr. Mann discusses on this site — benfotiamine combined with methylcobalamin — is sold as a nutritional product by a company he founded. That is a financial conflict of interest. We disclose it here, in the footer of every page, and again in a banner on every page that recommends a specific product or protocol.
The clinical claims on this site are grounded in peer-reviewed published research. See the bibliography for the primary sources behind each treatment claim.
Realm Labs, LLC
- Relationship: Founder, President, and CEO.
- What they make:NeuRemedy®, a benfotiamine-based nutritional product Dr. Mann prescribes and writes about.
- Website: realmlabs.net/
Pryde Pharmaceuticals, Inc.
- Relationship: Founder, President, and CEO.
- What they make:Topical analgesic products for peripheral neuropathy. Discussed only in passing on this site; not the protocol’s focus.
Scientific & medical consulting
Dr. Mann has consulted with Orthotics Holdings Inc. on the management of polyneuropathy and peripheral neuropathy. No consulting income from companies whose products are discussed on this site beyond Realm Labs.
Editorial independence
No external sponsor reviews or approves clinical content before publication. The site’s content is authored or approved by Dr. Mann personally, and every meaningful clinical claim links to a peer-reviewed citation.
The content on this site is not to be considered medical advice. It does not establish a doctor/patient relationship in any form between the reader, Dr. Mann, and/or his employees.